Eigentx
Redwood City, US Β· 2 known investors
Eigen develops co-therapies that modulate cancer cell target expression to improve the effectiveness of targeted treatments such as antibody-drug conjugates and radioligand therapies. It uses a discovery platform combining machine learning, robotic automation, and high-throughput combinatorial screening to design combination therapies addressing tumor heterogeneity.
AI & Machine LearningBiotechRobotics
Investors Β· 2
Frequently asked questions
- What does Eigentx do?
- Eigen develops co-therapies that modulate cancer cell target expression to improve the effectiveness of targeted treatments such as antibody-drug conjugates and radioligand therapies. It uses a discovery platform combining machine learning, robotic automation, and high-throughput combinatorial screening to design combination therapies addressing tumor heterogeneity.
- Who are Eigentx's investors?
- Eigentx's investors include SBXi, ZAKA VC.
- Where is Eigentx headquartered?
- Eigentx is headquartered in Redwood City, US.